Fisher Mark, Moores Lisa, Alsharif Mohamad N, Paganini-Hill Annlia
Department of Neurology, University of California Irvine.
Department of Nursing Quality, Research, & Education, University of California Irvine Medical Center, Orange.
JAMA Neurol. 2016 Feb;73(2):186-9. doi: 10.1001/jamaneurol.2015.3587.
Although patients with acute stroke are routinely evaluated for potential treatment (ie, treatability of the stroke), preventability of the presenting stroke is generally not seriously considered.
To systematically analyze stroke preventability.
DESIGN, SETTING, AND PARTICIPANTS: We evaluated medical records of 274 consecutive patients discharged with a diagnosis of ischemic stroke between December 2, 2010, and June 11, 2012, at the University of California Irvine Medical Center. Mean (SE) patient age was 67.2 (0.8) years. Data analysis was conducted from July 3, 2014, to August 4, 2015.
Medical records were systematically examined for demographic information, stroke risk factors, stroke severity, and acute stroke treatment.
We defined stroke preventability as the degree to which the patient's presenting stroke was preventable. Using variables easily determined at onset of stroke, we developed a 10-point scale (0, not preventable; 10, most preventable) to classify the degree of stroke preventability. Our focus was effectiveness of treatment of hypertension (0-2 points), hyperlipidemia (0-2 points), and atrial fibrillation (0-4 points), as well as use of antithrombotic treatment for known prior cerebrovascular and cardiovascular disease (0-2 points).
Total risk scores ranged from 0 to 8 (mean [SE], 2.2 [0.1]), with 207 patients (75.5%) exhibiting some degree of preventability (score of 1 or higher). Seventy-one patients (25.9%) had scores of 4 or higher, indicating that the stroke was highly preventable. Severity of stroke as determined by the National Institutes of Health Stroke Scale score was not related to preventability of stroke. However, 21 of 71 patients (29.6%) whose stroke was highly preventable were treated with intravenous or intra-arterial acute stroke therapy while these treatments were provided for only 13 of 67 patients (19.4%) with scores of 0 (no preventability) and 19 of 136 patients (14.0%) with scores of 1 to 3 (low preventability) (P = .03).
Most patients with acute stroke exhibited some degree of preventability. Preventability and treatment of stroke were significantly associated, indicating that the most preventable strokes paradoxically were more likely to receive acute treatment.
尽管急性卒中患者会接受常规的潜在治疗评估(即卒中的可治疗性),但引发此次卒中的可预防性通常未得到认真考虑。
系统分析卒中的可预防性。
设计、地点和参与者:我们评估了2010年12月2日至2012年6月11日期间在加州大学欧文医学中心连续出院的274例诊断为缺血性卒中患者的病历。患者平均(标准误)年龄为67.2(0.8)岁。数据分析于2014年7月3日至2015年8月4日进行。
系统检查病历以获取人口统计学信息、卒中危险因素、卒中严重程度和急性卒中治疗情况。
我们将卒中可预防性定义为患者此次卒中可预防的程度。利用卒中发作时易于确定的变量,我们制定了一个10分制量表(0分表示不可预防;10分表示最可预防)来对卒中可预防程度进行分类。我们关注的重点是高血压治疗效果(0 - 2分)、高脂血症治疗效果(0 - 2分)、心房颤动治疗效果(0 - 4分),以及针对已知既往脑血管和心血管疾病使用抗栓治疗的情况(0 - 2分)。
总风险评分范围为0至8(平均[标准误],2.2[0.1]),207例患者(75.5%)表现出一定程度的可预防性(评分1分或更高)。71例患者(25.9%)评分4分或更高,表明卒中高度可预防。由美国国立卫生研究院卒中量表评分确定的卒中严重程度与卒中可预防性无关。然而,71例卒中高度可预防的患者中有21例(29.6%)接受了静脉或动脉急性卒中治疗,而在评分0分(无可预防性)的67例患者中只有13例(19.4%)接受了这些治疗,在评分1至3分(低可预防性)的136例患者中有19例(14.0%)接受了这些治疗(P = 0.03)。
大多数急性卒中患者表现出一定程度的可预防性。卒中的可预防性与治疗显著相关,这表明最可预防的卒中反而更有可能接受急性治疗。